EyePoint Pharmaceuticals (EYPT) Reports Q1 Earnings: What Key Metrics Have to Say

For the quarter ended March 2025, EyePoint Pharmaceuticals (EYPT) reported revenue of $24.45 million, up 109.4% over the same period last year. EPS came in at -$ 0.65, compared to - $0.55 in the year-ago quarter.The reported revenue represents a surprise of +345.17% over the Zacks Consensus Estimate of$ 5.49 million. With the consensus EPS estimate being -$0.65, the company has not delivered EPS surprise.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and ho ...